These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


559 related items for PubMed ID: 7840856

  • 21. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA.
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
    Tisch R, Yang XD, Liblau RS, McDevitt HO.
    J Autoimmun; 1994 Dec; 7(6):845-50. PubMed ID: 7888040
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M, Masumura M, Tomi C, Chiba A, Oki S, Yamamura T, Miyake S.
    J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
    [Abstract] [Full Text] [Related]

  • 30. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R, Wang B, Serreze DV.
    J Immunol; 1999 Aug 01; 163(3):1178-87. PubMed ID: 10415012
    [Abstract] [Full Text] [Related]

  • 31. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr 01; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH.
    J Immunol; 1996 Aug 01; 157(3):1279-87. PubMed ID: 8757636
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
    Choi SE, Kim KS, Kim KH, Choi UY, Kim HM, Yoon JW, Kang Y.
    J Autoimmun; 2000 Nov 01; 15(3):347-57. PubMed ID: 11040075
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D, Chaillous L, Rohmer V, Lecomte P, Marechaud R, Saï P, Marre M, Charbonnel B, Allannic H, Delamaire M.
    Diabetes Metab; 1997 Sep 01; 23(4):320-6. PubMed ID: 9342546
    [Abstract] [Full Text] [Related]

  • 40. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.
    Diabetes; 2008 May 01; 57(5):1321-30. PubMed ID: 18299317
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.